Article Text

Download PDFPDF
Radiologically confirmed pneumonia among neonates and very young infants
  1. Raquel Simbalista1,
  2. Marcelo Araújo2,
  3. Cristiana M Nascimento-Carvalho3
  1. 1Post-Graduation Program, Federal University of Bahia School of Medicine, Salvador, Brazil
  2. 2Image Memorial Unit, Bahia Hospital, Salvador, Brazil
  3. 3Department of Paediatrics, Federal University of Bahia School of Medicine, Salvador, Brazil
  1. Correspondence to Professor Cristiana M Nascimento-Carvalho, Department of Paediatrics, Federal University of Bahia School of Medicine, Rua Prof Aristides Novis, 105/1201B, Salvador, Bahia CEP 40210-630, Brazil; nascimentocarvalho{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Pneumonia is one of the world major causes of death in neonates1 and age <2 months was identified as an independent risk factor for death.2 According to international guidelines, infants <2 months of age with pneumonia diagnosed on clinical grounds, irrespective of the chest x-ray (CXR) evaluation, must be hospitalised and receive intravenous antibiotics.2 ,3 Although much has been published on pneumonia among neonates, management algorithms include infants aged less than 2 months together but homogeneity has not been reported in this age group. Our aim was to compare clinical and radiological parameters between neonates and infants aged 1–2 months.

We reviewed all cases <2 months of age admitted with pneumonia diagnosed on clinical grounds at Federal University of Bahia Hospital, in Salvador, Brazil, in a 37-month period. All patients came from the community and were referred …

View Full Text


  • Contributors CMN-C designed the study; RS reviewed the medical charts, collected and entered the data; MA read the chest x-rays. All authors analysed the data. RS drafted the manuscript. MA contributed to the writing and CMN-C proofread the manuscript.

  • Funding There was no specific funding for this investigation. CMN-C is investigator of the Brazilian Council for Scientific and Technological Development (CNPq).

  • Competing interests None.

  • Ethics approval Ethics Committee of the Federal University of Bahia.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Data sharing statement There are unpublished data on the evolution of the 90 studied patients that were not included in this manuscript and are with CMN-C.